NCT07244393 2025-11-24Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate CancerCellbion Co., Ltd.Phase 1 Not yet recruiting30 enrolled
NCT06344715 2024-04-03Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.SL VAXiGENPhase 1 Recruiting78 enrolled